story of the week
Assessment of Pembrolizumab for the Treatment of Microsatellite Instability–High Gastric or Gastroesophageal Junction Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials
JAMA Oncol 2021 Jun 01;7(6)895-902, J Chao, CS Fuchs, K Shitara, J Tabernero, K Muro, E Van Cutsem, YJ Bang, F De Vita, G Landers, CJ Yen, I Chau, A Elme, J Lee, M Özgüroglu, D Catenacci, HH Yoon, E Chen, D Adelberg, CS Shih, S Shah, P Bhagia, ZA WainbergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.